FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2905996896> ?p ?o ?g. }

• W2905996896 endingPage "S39" @default.
• W2905996896 startingPage "S35" @default.
• W2905996896 abstract "Les injections de lymphocytes du donneur (DLI) peuvent être proposées pour traiter ou prévenir la rechute d’une hémopathie maligne après allogreffe de cellules souches hématopoïétiques. L’efficacité est principalement rapportée dans le traitement de la leucémie myéloïde chronique et les lymphomes à caractère indolent. L’activité antitumorale est moindre pour les leucémies aiguës et les syndromes myélodysplasiques. L’effet bénéfique « greffon versus leucémie » (GVL) doit toujours être évalué par rapport à la morbi-mortalité possible liée à la réaction du greffon contre l’hôte (GVHD). Les premières recommandations de la SFGM-TC de 2013 concernant l’utilisation des DLI sont mises à jour. Les doses de DLI dans le cadre des greffes haplo-identiques sont indiquées. L’excédent de cellules souches périphériques mobilisées par rhG-CSF peut être utilisé comme DLI. La définition et la place des DLI préemptives et prophylactiques sont précisées. Des recommandations sont également proposées concernant l’évaluation de la qualité des DLI décongelées et le suivi clinique et biologique après DLI. Donor lymphocyte infusion (DLI) can be proposed to treat or prevent the relapse of malignant hemopathies following allogeneic stem cell transplantation. The efficiency has been mainly reported in the treatment of CML and low-grade lymphomas while the anti-tumoral activity is less in forms of acute leukemia and myelodysplastic syndromes. The GVL benefit should always be compared to the possible toxic effects of GVHD. This article updates the initial SFGM-TC recommendations, proposed in 2013, that were focused on the use of DLI. Doses of DLI in the context of haplo-identical stem cell transplantation are now indicated. We confirm that remaining mobilized stem cells may be used as classical DLI. The definition and the place of preemptive and prophylactic DLI are precisely given. Recommendations regarding the quality of thawed DLI as well as necessary clinical and biological follow-up are also described in detail." @default.
• W2905996896 created "2019-01-01" @default.
• W2905996896 creator A5006076814 @default.
• W2905996896 creator A5007731800 @default.
• W2905996896 creator A5026982361 @default.
• W2905996896 creator A5032551623 @default.
• W2905996896 creator A5033653886 @default.
• W2905996896 creator A5037384925 @default.
• W2905996896 creator A5041008830 @default.
• W2905996896 creator A5042424335 @default.
• W2905996896 creator A5050987906 @default.
• W2905996896 creator A5067775008 @default.
• W2905996896 creator A5072757261 @default.
• W2905996896 creator A5080373266 @default.
• W2905996896 creator A5082072135 @default.
• W2905996896 creator A5085684624 @default.
• W2905996896 creator A5088615635 @default.
• W2905996896 date "2019-01-01" @default.
• W2905996896 modified "2023-10-11" @default.
• W2905996896 title "Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)" @default.
• W2905996896 cites W1776408811 @default.
• W2905996896 cites W1972644623 @default.
• W2905996896 cites W1988779573 @default.
• W2905996896 cites W2029047332 @default.
• W2905996896 cites W2037851183 @default.
• W2905996896 cites W2043127064 @default.
• W2905996896 cites W2046843493 @default.
• W2905996896 cites W2055073381 @default.
• W2905996896 cites W2058512747 @default.
• W2905996896 cites W2074681088 @default.
• W2905996896 cites W2076767294 @default.
• W2905996896 cites W2088859046 @default.
• W2905996896 cites W2091569912 @default.
• W2905996896 cites W2107514081 @default.
• W2905996896 cites W2109948637 @default.
• W2905996896 cites W2117375900 @default.
• W2905996896 cites W2148388235 @default.
• W2905996896 cites W2149412463 @default.
• W2905996896 cites W2357277758 @default.
• W2905996896 cites W2406229469 @default.
• W2905996896 cites W2424060136 @default.
• W2905996896 cites W2547524718 @default.
• W2905996896 cites W2557011256 @default.
• W2905996896 cites W2567601891 @default.
• W2905996896 cites W2766106189 @default.
• W2905996896 doi "https://doi.org/10.1016/j.bulcan.2018.10.002" @default.
• W2905996896 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30580911" @default.
• W2905996896 hasPublicationYear "2019" @default.
• W2905996896 type Work @default.
• W2905996896 sameAs 2905996896 @default.
• W2905996896 citedByCount "9" @default.
• W2905996896 countsByYear W29059968962019 @default.
• W2905996896 countsByYear W29059968962021 @default.
• W2905996896 countsByYear W29059968962022 @default.
• W2905996896 countsByYear W29059968962023 @default.
• W2905996896 crossrefType "journal-article" @default.
• W2905996896 hasAuthorship W2905996896A5006076814 @default.
• W2905996896 hasAuthorship W2905996896A5007731800 @default.
• W2905996896 hasAuthorship W2905996896A5026982361 @default.
• W2905996896 hasAuthorship W2905996896A5032551623 @default.
• W2905996896 hasAuthorship W2905996896A5033653886 @default.
• W2905996896 hasAuthorship W2905996896A5037384925 @default.
• W2905996896 hasAuthorship W2905996896A5041008830 @default.
• W2905996896 hasAuthorship W2905996896A5042424335 @default.
• W2905996896 hasAuthorship W2905996896A5050987906 @default.
• W2905996896 hasAuthorship W2905996896A5067775008 @default.
• W2905996896 hasAuthorship W2905996896A5072757261 @default.
• W2905996896 hasAuthorship W2905996896A5080373266 @default.
• W2905996896 hasAuthorship W2905996896A5082072135 @default.
• W2905996896 hasAuthorship W2905996896A5085684624 @default.
• W2905996896 hasAuthorship W2905996896A5088615635 @default.
• W2905996896 hasBestOaLocation W29059968961 @default.
• W2905996896 hasConcept C29456083 @default.
• W2905996896 hasConcept C71924100 @default.
• W2905996896 hasConceptScore W2905996896C29456083 @default.
• W2905996896 hasConceptScore W2905996896C71924100 @default.
• W2905996896 hasFunder F4320307765 @default.
• W2905996896 hasFunder F4320307769 @default.
• W2905996896 hasFunder F4320307781 @default.
• W2905996896 hasFunder F4320308573 @default.
• W2905996896 hasFunder F4320309470 @default.
• W2905996896 hasIssue "1" @default.
• W2905996896 hasLocation W29059968961 @default.
• W2905996896 hasLocation W29059968962 @default.
• W2905996896 hasLocation W29059968963 @default.
• W2905996896 hasLocation W29059968964 @default.
• W2905996896 hasLocation W29059968965 @default.
• W2905996896 hasOpenAccess W2905996896 @default.
• W2905996896 hasPrimaryLocation W29059968961 @default.
• W2905996896 hasRelatedWork W1506200166 @default.
• W2905996896 hasRelatedWork W1995515455 @default.
• W2905996896 hasRelatedWork W2048182022 @default.
• W2905996896 hasRelatedWork W2080531066 @default.
• W2905996896 hasRelatedWork W2604872355 @default.
• W2905996896 hasRelatedWork W2748952813 @default.
• W2905996896 hasRelatedWork W2899084033 @default.
• W2905996896 hasRelatedWork W3031052312 @default.
• W2905996896 hasRelatedWork W3032375762 @default.

• next